Utilization of evidence-based secondary prevention medications at the time of discharge in patients with acute coronary syndrome (ACS) in Qatar Academic Article Article uri icon

Overview

MeSH Major

  • Antibodies, Monoclonal
  • Antineoplastic Agents
  • Antiretroviral Therapy, Highly Active
  • Burkitt Lymphoma
  • Lymphoma, AIDS-Related

abstract

  • Most ACS patients were prescribed antiplatelets, β-blockers and statins, but the use of ACEIs or ARBs was suboptimal. Strategies are needed to enhance ACEI or ARB prescribing, especially for high risk patients who would have the greatest therapeutic benefit from these drugs.

publication date

  • July 2016

Research

keywords

  • Academic Article

Identity

PubMed ID

  • 26916397

Additional Document Info

start page

  • 394

end page

  • 403

volume

  • 14

number

  • 4